These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8921529)

  • 21. Corticobasal degeneration as a cognitive disorder.
    Graham NL; Bak TH; Hodges JR
    Mov Disord; 2003 Nov; 18(11):1224-32. PubMed ID: 14639661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological diagnosis of progressive supranuclear palsy and related disorders.
    Ikeda K; Akiyama H
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1278-9. PubMed ID: 8957452
    [No Abstract]   [Full Text] [Related]  

  • 23. Cortico-basal ganglionic degeneration--a frequently undetected syndrome.
    Anand KS; Biswas A; Prasad A
    Neurol India; 2000 Dec; 48(4):405-6. PubMed ID: 11146617
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy.
    Ikeda K; Akiyama H; Haga C; Kondo H; Arima K; Oda T
    Neurosci Lett; 1994 Jun; 174(2):157-9. PubMed ID: 7526285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of corticobasal degeneration presenting with primary progressive aphasia].
    Katai S; Maruyama T; Nakamura A; Tokuda T; Shindo M; Yanagisawa N
    Rinsho Shinkeigaku; 1997 Mar; 37(3):249-52. PubMed ID: 9217426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration.
    Giladi N; Fahn S
    Mov Disord; 1992 Oct; 7(4):384-5. PubMed ID: 1484539
    [No Abstract]   [Full Text] [Related]  

  • 28. The many faces of corticobasal degeneration.
    Wadia PM; Lang AE
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S336-40. PubMed ID: 18267261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.
    Boeve BF; Lang AE; Litvan I
    Ann Neurol; 2003; 54 Suppl 5():S15-9. PubMed ID: 12833363
    [No Abstract]   [Full Text] [Related]  

  • 30. [Corticobasal degeneration. Description of a consanguineous case].
    Giroud Benítez JL; Alvarez González E; Alvarez González L
    Rev Neurol; 2001 Nov 16-30; 33(10):999. PubMed ID: 11785021
    [No Abstract]   [Full Text] [Related]  

  • 31. [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy].
    Hattori M; Yoshida M; Ojika K; Yuasa H; Mitake S; Hashizume Y
    Rinsho Shinkeigaku; 2000 Apr; 40(4):372-7. PubMed ID: 10967656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.
    Bergeron C; Pollanen MS; Weyer L; Lang AE
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argyrophilic grains are reliable disease-specific features of corticobasal degeneration.
    Tatsumi S; Mimuro M; Iwasaki Y; Takahashi R; Kakita A; Takahashi H; Yoshida M
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):30-8. PubMed ID: 24335531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
    Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
    Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticobasal degeneration.
    Thompson PD; Marsden CD
    Baillieres Clin Neurol; 1992 Nov; 1(3):677-86. PubMed ID: 1344208
    [No Abstract]   [Full Text] [Related]  

  • 37. [P300 findings in patients with corticobasal degeneration].
    Homma A; Harayama H; Kondo H; Sato M; Saito Y; Hayashi T; Soma Y; Tsuji S
    No To Shinkei; 1996 Oct; 48(10):925-9. PubMed ID: 8921531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration.
    Uchihara T; Mizusawa H; Tsuchiya K; Kondo H; Oda T; Ikeda K
    Acta Neuropathol; 1998 Dec; 96(6):553-7. PubMed ID: 9845283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidental corticobasal degeneration.
    Martínez-Maldonado A; Luna-Muñoz J; Ferrer I
    Neuropathol Appl Neurobiol; 2016 Dec; 42(7):659-663. PubMed ID: 27461552
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
    Caparros-Lefebvre D; Kerdraon O; Devos D; Dhaenens CM; Blum D; Maurage CA; Delacourte A; Sablonnière B
    Mov Disord; 2009 May; 24(7):1089-90. PubMed ID: 19243029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.